Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Masato Odawara
Izumi Hamada
Manabu Suzuki
机构：
[1] Tokyo Medical University,The Third Department of Internal Medicine
[2] Novartis Pharma K.K.,undefined
来源：
Diabetes Therapy | 2014年 / 5卷
关键词：
Antidiabetic drug; Dipeptidyl peptidase-4 inhibitor; Glycemic control; Metformin; Randomized trial; Type 2 diabetes mellitus; Vildagliptin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：169 / 181
页数：12
相关论文
共 50 条
  • [1] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Odawara, Masato
    Hamada, Izumi
    Suzuki, Manabu
    [J]. DIABETES THERAPY, 2014, 5 (01) : 169 - 181
  • [2] Efficacy and tolerability of vildagliptin as an add-on to nateglinide in Japanese patients with type 2 diabetes mellitus
    Fujimaki, K.
    Hirose, T.
    Someya, Y.
    Yoshihara, T.
    Fujitani, Y.
    Watada, H.
    [J]. DIABETOLOGIA, 2012, 55 : S357 - S357
  • [3] Efficacy and tolerability of vildagliptin as an add-on to glimepiride in Japanese patients with Type 2 diabetes mellitus
    Kikuchi, Masatoshi
    Haneda, Masakazu
    Koya, Daisuke
    Tobe, Kazuyuki
    Onishi, Yukiko
    Couturier, Andre
    Mimori, Nobuyuki
    Inaba, Yoko
    Goodman, Matthew
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 89 (03) : 216 - 223
  • [4] Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus
    Pan, C.
    Xing, X.
    Han, P.
    Zheng, S.
    Ma, J.
    Liu, J.
    Lv, X.
    Lu, J.
    Bader, G.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (08): : 737 - 744
  • [5] Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany
    Goke, R.
    Gruenberger, J. B.
    Bader, G.
    Dworak, M.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (05) : 785 - 789
  • [6] Efficacy and safety of supaglutide as add-on to metformin in patients with type 2 diabetes
    Anwar, D.
    Bao, Y.
    Zhou, Y.
    Chen, S.
    Zhou, J.
    Li, L.
    Cheng, Z.
    Dong, X.
    Shi, X.
    Zhao, N.
    Yang, Y.
    Ma, J.
    Li, Y.
    Wang, Q.
    Jia, W.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S322 - S322
  • [7] Efficacy and Safety of Supaglutide as Add-on to Metformin in Patients with Type 2 Diabetes
    Anwar, Dilbar
    Bao, Yuqian
    Zhou, Yue
    Chen, Si
    Zhou, Jian
    Li, Liang
    Cheng, Zhifeng
    Dong, Xiaolin
    Shi, Xiaoxia
    Su, Xiuhai
    Li, Liping
    Wang, Haifang
    Wang, Yihua
    Li, Shu
    Li, Qingju
    Li, Xing
    Liu, Ming
    Sun, Jiao
    Zhao, Naiqing
    Yang, Yehong
    Ma, Jianhua
    Li, Yiming
    Wang, Qinghua
    Jia, Weiping
    [J]. DIABETES, 2023, 72
  • [8] Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study
    Hirose, Takahisa
    Suzuki, Manabu
    Tsumiyama, Isao
    [J]. DIABETES THERAPY, 2015, 6 (04) : 559 - 571
  • [9] Efficacy and Safety of Vildagliptin as an Add-on to Insulin with or without Metformin in Japanese Patients with Type 2 Diabetes Mellitus: A 12-week, Double-Blind, Randomized Study
    Takahisa Hirose
    Manabu Suzuki
    Isao Tsumiyama
    [J]. Diabetes Therapy, 2015, 6 : 559 - 571
  • [10] Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey - GALATA study
    Ayvaz, Goksun
    Keskin, Lezzan
    Akin, Fulya
    Dokmetas, Hatice Sebile
    Tasan, Ertugrul
    Ar, Idilhan Baloglu
    Uren, Emel
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (04) : 623 - 632
12345